评估莫桑比克HRP2抗原检测在疟疾诊断中的性能
该研究在莫桑比克三个省的117家随机选取的公共卫生机构中,对2018年就诊的1861名门诊患者样本使用超灵敏珠基免疫分析法检测PfHRP2、pAldo和pLDH,并与常规PfHRP2快速诊断试验(RDT)比较。以实验室珠基法为金标准,常规RDT在常规门诊和调查出口访谈中的敏感性分别为90%和83%,特异性分别为91%和97%。在710份至少一种抗原阳性的样本中,704份(99.2%)为PfHRP2阳性,6份(0.8%)为不一致样本,其中3份(0.4%)为卵形疟单感染或混合感染,另3份PET-PCR阴性,未发现Pfhrp2/Pfhrp3缺失虫株。
要点
- 常规PfHRP2 RDT在莫桑比克调查省份的敏感性和特异性可接受。
- 未检测到Pfhrp2和Pfhrp3基因缺失的恶性疟原虫。
- 非恶性疟原虫单感染占全部疟疾感染不足1%。
核心结论
- 在莫桑比克调查的三个省份,常规PfHRP2 RDT的敏感性和特异性可接受,且未发现Pfhrp2和Pfhrp3缺失虫株。
- 几乎所有疟疾抗原阳性患者均可检测到PfHRP2,表明该抗原仍是该地区合适的疟疾诊断靶标。
研究设计与样本
- 基于2018年莫桑比克三个省117家随机选取的公共卫生机构健康设施调查,纳入1861名各年龄段门诊患者。
- 样本用超灵敏珠基免疫分析法检测PfHRP2、pan-Plasmodium aldolase(pAldo)和pan-Plasmodium乳酸脱氢酶(pLDH),并与常规PfHRP2 RDT结果比较。
- 抗原谱不一致样本进一步用光诱导电子转移PCR(PET-PCR)表征。
主要发现
- 以珠基实验室法为金标准,常规RDT在常规门诊咨询时的敏感性为90%、特异性为91%。
- 调查出口访谈时常规RDT的敏感性为83%、特异性为97%。
- 710份至少一种抗原阳性样本中,704份(99.2%)为PfHRP2阳性。
- 6份(占总样本0.8%)不一致样本缺乏PfHRP2但pAldo和/或pLDH阳性,其中3份(占总样本0.4%)为卵形疟单感染或以卵形疟为优势种的混合感染。
- 其余3份不一致样本PET-PCR阴性。
关键数值与推荐
- 常规RDT敏感性:常规门诊90%,出口访谈83%(以珠基法为金标准)。
- 常规RDT特异性:常规门诊91%,出口访谈97%(以珠基法为金标准)。
- 非恶性疟原虫单感染占全部疟疾感染<1%。
临床怎么用
- 在莫桑比克调查省份,常规PfHRP2 RDT仍可作为疟疾诊断的合适工具。
- 临床解读RDT阴性结果时需注意其敏感性在出口访谈中为83%,存在漏检可能。
- 对于PfHRP2阴性但临床高度怀疑疟疾者,应考虑非恶性疟原虫感染可能。
局限性
- 研究仅覆盖莫桑比克三个省,结果外推至全国需谨慎。
- 不一致样本量小(6份),相关推断有限。
- 未报告其他潜在影响因素或混杂控制细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rapid diagnostic tests (RDTs) that detect the Plasmodium falciparum-specific histidine-rich protein 2 (PfHRP2) antigen are the primary methods for malaria diagnosis in Mozambique. However, these tests do not detect infections with non-falciparum malaria or Pfhrp2- and Pfhrp3-deleted P. falciparum parasites. To assess the appropriateness of conventional PfHRP2-only RDTs for malaria diagnosis in Mozambique, samples collected during a health facility survey conducted in three provinces of Mozambique were screened using antigen detection methods and further characterized by molecular techniques. Samples from 1,861 outpatients of all ages and symptoms attending 117 randomly selected public health facilities in 2018 were analyzed with an ultrasensitive bead-based immunoassay for the presence of PfHRP2, pan-Plasmodium aldolase (pAldo), and pan-Plasmodium lactate dehydrogenase (pLDH). The presence of PfHRP2 in patient blood detected using the bead-based assay was compared to the results of PfHRP2-based RDTs performed during the routine health facility consult and during the survey reexamination at the exit interview. Samples with discordant antigen profiles (negative for PfHRP2 but positive for pAldo and/or pLDH) were further characterized by photoinduced electron transfer PCR (PET-PCR). Using the bead-based laboratory assay as the gold standard, the sensitivities of the conventional RDTs administered during the routine health facility consult and the exit interview were 90% and 83%, respectively, and the specificities were 91% and 97%, respectively. Of 710 samples positive for at least one antigen, 704 (99.2%) were positive for PfHRP2. Six (0.8% of total) discordant samples lacked PfHRP2 but were positive for pAldo and/or pLDH; 3 of these (0.4% of total) were Plasmodium ovale monoinfections or coinfections where P. ovale was the dominant species. The remaining 3 discordant samples were negative by PET-PCR. The sensitivity and specificity of the conventional RDTs performed in the routine health facility consults and survey exit interviews were acceptable, and there was no evidence of Pfhrp2- and Pfhrp3-deleted parasites. Monoinfections with non-falciparum malaria species comprised <1% of the total malaria infections. Nearly all malaria antigen-positive patients had detectable PfHRP2, confirming that this antigen remains an appropriate malaria diagnostic target in the surveyed provinces.
引用
- Plucinski MM, Candrinho B, Dimene M, et al. Assessing Performance of HRP2 Antigen Detection for Malaria Diagnosis in Mozambique. J Clin Microbiol. 2019. PMID: 31270184. doi:10.1128/JCM.00875-19
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。